Onderneming Alcon, Inc.
Aandelen
ACL
CH0013826497
Medische apparatuur, benodigdheden & distributie
slotkoers
Andere beurzen
|
||
- USD | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 305 044 983 | 61 479 792 ( 20,15 %) | 2 654 717 ( 0,8703 %) | 20,15 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
ALCON INC. 1.29% | 6 438 707 | 1.29% | 573 881 955 $ |
Bedrijfsgegevens
Bedrijven van de groep
Naam | Categorie en sector |
---|---|
Alcon Laboratories (India) Pvt Ltd.
Alcon Laboratories (India) Pvt Ltd. Medical DistributorsDistribution Services Alcon Laboratories (India) Pvt Ltd. provides pharmaceutical products and services. The company is headquartered in Bangalore, India. |
Medical Distributors
|
Alcon Management SA
| |
Alcon Finance Corp.
Alcon Finance Corp. Finance/Rental/LeasingFinance Alcon Finance Corp.provides financing services. The company is headquartered in Delaware, United States. |
Finance/Rental/Leasing
|
Alcon Singapore Manufacturing Pte Ltd.
Alcon Singapore Manufacturing Pte Ltd. Pharmaceuticals: MajorHealth Technology Part of Alcon AG, Alcon Singapore Manufacturing Pte Ltd. is a company that engages in chemical preparations. The company is based in Singapore, Singapore. |
Pharmaceuticals: Major
|
Alcon Pharmaceuticals Ltd.
Alcon Pharmaceuticals Ltd. Medical SpecialtiesHealth Technology Alcon Pharmaceuticals Ltd. supplies pharmaceuticals products. The company is headquartered in Fribourg, Switzerland. |
Medical Specialties
|
Alcon Laboratories Belgium BVBA
Alcon Laboratories Belgium BVBA Pharmaceuticals: MajorHealth Technology Part of Alcon AG, Alcon Laboratories Belgium BV is a Belgian company that manufactures medicines. The company is located in Belgium. |
Pharmaceuticals: Major
|
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,78% | 100 mld. | |
-7,03% | 17,51 mld. | |
-27,37% | 2,02 mld. | |
+12,91% | 1,89 mld. | |
+21,69% | 1,15 mld. | |
+70,25% | 676 mln. | |
-9,57% | 651 mln. | |
-45,65% | 628 mln. | |
-43,70% | 624 mln. |